litlas
Log inCreate account

Paul E. Sax

Active 1995–2025

110
Papers
20,190
Citations
73
h-index
106
i10-index

Citations

Citations per year for Paul E. Sax1998: 30 citations1999: 58 citations2000: 60 citations2001: 96 citations2002: 91 citations2003: 94 citations2004: 73 citations2005: 83 citations2006: 85 citations2007: 73 citations2008: 86 citations2009: 77 citations2010: 91 citations2011: 92 citations2012: 107 citations2013: 99 citations2014: 104 citations2015: 117 citations2016: 142 citations2017: 86 citations2018: 125 citations2019: 532 citations2020: 555 citations2021: 618 citations2022: 423 citations2023: 346 citations2024: 595 citations2025: 163 citations2026: 10 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,234 citing papers, 31.2% of this breakdownUnited Kingdom: 602 citing papers, 8.4% of this breakdownFrance: 358 citing papers, 5% of this breakdownSpain: 327 citing papers, 4.6% of this breakdownItaly: 294 citing papers, 4.1% of this breakdownCanada: 271 citing papers, 3.8% of this breakdownSouth Africa: 245 citing papers, 3.4% of this breakdownGermany: 230 citing papers, 3.2% of this breakdownSwitzerland: 212 citing papers, 3% of this breakdownChina: 207 citing papers, 2.9% of this breakdownAustralia: 189 citing papers, 2.7% of this breakdownNetherlands: 165 citing papers, 2.3% of this breakdown
0%31.2%Other 25.4%

Institutions

Fields

  • Medicine73.6%
  • Immunology and Microbiology18%
  • Biochemistry, Genetics and Molecular Biology3%
  • Mathematics0.9%
  • Pharmacology, Toxicology and Pharmaceutics0.9%
  • Health Professions0.7%
  • Other2.9%

Topics

  • HIV Research and Treatment13.5%
  • HIV/AIDS drug development and treatment13.1%
  • HIV/AIDS Research and Interventions12%
  • HIV-related health complications and treatments10.6%
  • Immune Cell Function and Interaction3.1%
  • SARS-CoV-2 and COVID-19 Research2.2%
  • Other45.5%

Coauthors

All papers

Open in search
  1. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults

    Authors: Rajesh T. Gandhi, Roger Bedimo, Jennifer Hoy, Raphael J. Landovitz, Davey M. Smith, Ellen Eaton, Clara Lehmann, Sandra A. Springer, Paul E. Sax, Melanie Thompson, Constance A. Benson, Susan Buchbinder, Carlos del Rı́o, Joseph J. Eron, Huldrych F. Günthard, Jean‐Michel Molina, Donna M. Jacobsen, Michael S. Saag - JAMA 2022 cited by 551

  2. Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials

    Authors: Paul E. Sax, Kristine M. Erlandson, Jordan E. Lake, Grace A. McComsey, Chloe Orkin, Stefan Eßer, Todd T. Brown, Jürgen K. Rockstroh, Xuelian Wei, Christoph C Carter, Lijie Zhong, Diana M. Brainard, Kathleen Melbourne, Moupali Das, Hans-Jürgen Stellbrink, Frank A. Post, Laura Waters, John R. Koethe - Clinical Infectious Diseases 2019 cited by 750

  3. Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial

    Authors: Paul E. Sax, Anton Pozniak, Marisa Montes, Ellen Koenig, Edwin DeJesus, Hans-Jürgen Stellbrink, Andrea Antinori, Kimberly Workowski, Jihad Slim, Jacques Reynes, Will Garner, Joseph M. Custodio, Kirsten White, Devi SenGupta, Andrew Cheng, Erin Quirk - The Lancet 2017 cited by 395

  4. Weight Change Following Antiretroviral Therapy Switch in People With Viral Suppression: Pooled Data from Randomized Clinical Trials

    Authors: Kristine M. Erlandson, Christoph C Carter, Kathleen Melbourne, Todd T. Brown, Cal Cohen, Moupali Das, Stefan Eßer, Hailin Huang, John R. Koethe, Hal Martin, Grace A. McComsey, Chloe Orkin, Frank A. Post, Jürgen K. Rockstroh, Paul E. Sax, Hans‐Jürgen Stellbrink, Laura Waters, Xuelian Wei, Jordan E. Lake - Clinical Infectious Diseases 2021 cited by 114

  5. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults

    Authors: Huldrych F. Günthard, Michael S. Saag, Constance A. Benson, Carlos del Rı́o, Joseph J. Eron, Joel E. Gallant, Jennifer Hoy, Michael J. Mugavero, Paul E. Sax, Melanie Thompson, Rajesh T. Gandhi, Raphael J. Landovitz, Davey M. Smith, Donna M. Jacobsen, Paul A. Volberding - JAMA 2016 cited by 656

  6. Bictegravir/emtricitabine/tenofovir alafenamide as initial treatment for HIV-1: five-year follow-up from two randomized trials

    Authors: Paul E. Sax, José Ramón Arribas, Chloe Orkin, Adriano Lazzarin, Anton Pozniak, Edwin DeJesus, Franco Maggiolo, Hans‐Jürgen Stellbrink, Yazdan Yazdanpanah, Rima Acosta, Hailin Huang, Jason T. Hindman, Hal D. Martin, Jared M. Baeten, David A. Wohl - EClinicalMedicine 2023 cited by 85

  7. Oral Nirmatrelvir and Ritonavir in Nonhospitalized Vaccinated Patients With Coronavirus Disease 2019

    Authors: Sarju Ganatra, Sourbha S. Dani, Javaria Ahmad, Ashish Kumar, Jui Shah, George M. Abraham, Daniel P. McQuillen, Robert M. Wachter, Paul E. Sax - Clinical Infectious Diseases 2022 cited by 154

  8. Updated Treatment Recommendation on Use of Cabotegravir and Rilpivirine for People With HIV From the IAS-USA Guidelines Panel

    Authors: Paul E. Sax, Melanie Thompson, Michael S. Saag, IAS-USA Treatment Guidelines Panel - JAMA 2024 cited by 51

  9. Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial

    Authors: Shahin Lockman, Sean S. Brummel, Lauren Ziemba, Lynda Stranix‐Chibanda, Katie McCarthy, Anne Coletti, Patrick Jean‐Philippe, Ben Johnston, Chelsea Krotje, Lee Fairlie, Risa M. Hoffman, Paul E. Sax, Sikhulile Moyo, Nahida Chakhtoura, Jeffrey S. A. Stringer, Gaerolwe Masheto, Violet Korutaro, Haseena Cassim, Blandina T. Mmbaga, Esaú João, Sherika Hanley, Lynette Purdue, Lewis B. Holmes, Jeremiah D. Momper, Roger Shapiro, Navdeep Thoofer, James F. Rooney, Lisa M. Frenkel, K. Rivet Amico, Lameck Chinula, Judith S. Currier, Brookie M. Best, Cheryl Blanchette, Renee Browning, Yao Cheng, Andee Fox, Nagawa Jaliaah, Kevin Knowles, Mark Mirochnick, William Murtaugh, Emmanuel Patras, Mauricio Pinilla, Jean van Wyk, Frances Whalen - The Lancet 2021 cited by 160

  10. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults

    Authors: Michael S. Saag, Rajesh T. Gandhi, Jennifer Hoy, Raphael J. Landovitz, Melanie Thompson, Paul E. Sax, Davey M. Smith, Constance A. Benson, Susan Buchbinder, Carlos del Rı́o, Joseph J. Eron, Gerd Fätkenheuer, Huldrych F. Günthard, Jean‐Michel Molina, Donna M. Jacobsen, Paul A. Volberding - JAMA 2020 cited by 467

  11. Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors

    Authors: Eric A. Meyerowitz, Aaron Richterman, Rajesh T. Gandhi, Paul E. Sax - Annals of Internal Medicine 2020 cited by 798

  12. Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trials

    Authors: Chloe Orkin, Edwin DeJesus, Paul E. Sax, José Ramón Arribas, Samir K. Gupta, Claudia Martorell, Jeffrey L. Stephens, Hans‐Jürgen Stellbrink, David A. Wohl, Franco Maggiolo, Melanie Thompson, Daniel Podzamczer, Debbie Hagins, Jason Flamm, Cynthia Brinson, Amanda Clarke, Hailin Huang, Rima Acosta, Diana M. Brainard, Sean E Collins, Hal Martin - The Lancet HIV 2020 cited by 136

  13. Remdesivir Treatment in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19): A Comparative Analysis of In-hospital All-cause Mortality in a Large Multicenter Observational Cohort

    Authors: Essy Mozaffari, Aastha Chandak, Zhiji Zhang, Shuting Liang, Mark Thrun, Robert Gottlieb, Daniel R. Kuritzkes, Paul E. Sax, David A. Wohl, Roman Casciano, Paul Hodgkins, Richard Haubrich - Clinical Infectious Diseases 2021 cited by 123

  14. Two-drug regimens for HIV treatment

    Authors: Kevin M Gibas, Sean G. Kelly, José Ramón Arribas, Pedro Cahn, Chloe Orkin, Eric S. Daar, Paul E. Sax, Babafemi Taiwo - The Lancet HIV 2022 cited by 72

  15. Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel

    Authors: Rajesh T. Gandhi, Raphael J. Landovitz, Paul E. Sax, Davey M. Smith, Sandra A. Springer, Huldrych F. Günthard, Melanie Thompson, Roger Bedimo, Constance A. Benson, Susan Buchbinder, Brenda Crabtree‐Ramírez, Carlos del Rı́o, Ellen Eaton, Joseph J. Eron, Jennifer Hoy, Clara Lehmann, Jean‐Michel Molina, Donna M. Jacobsen, Michael S. Saag - JAMA 2024 cited by 202

  16. Switching to Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Virologically Suppressed Adults With Human Immunodeficiency Virus

    Authors: Paul E. Sax, Jürgen K. Rockstroh, Anne F. Luetkemeyer, Yazdan Yazdanpanah, Douglas Ward, Benoît Trottier, Armin Rieger, Hui Liu, Rima Acosta, Sean E Collins, Diana M. Brainard, Hal Martin, GS-US-380–4030 Investigators - Clinical Infectious Diseases 2020 cited by 112

  17. Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate

    Authors: Samir K. Gupta, Frank A. Post, José Ramón Arribas, Joseph J. Eron, David A. Wohl, Amanda E. Clarke, Paul E. Sax, Hans‐Jürgen Stellbrink, Stefan Eßer, Anton Pozniak, Daniel Podzamczer, Laura Waters, Chloe Orkin, Jürgen K. Rockstroh, Tatiana Mudrikova, Eugènia Negredo, Richard Elion, Susan Guo, Lijie Zhong, Christoph C Carter, Hal Martin, Diana M. Brainard, Devi SenGupta, Moupali Das - AIDS 2019 cited by 160

  18. Co-formulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial

    Authors: Hans‐Jürgen Stellbrink, José Ramón Arribas, Jeffrey L. Stephens, Helmut Albrecht, Paul E. Sax, Franco Maggiolo, Catherine Creticos, Claudia Martorell, Xuelian Wei, Rima Acosta, Sean E Collins, Diana M. Brainard, Hal Martin - The Lancet HIV 2019 cited by 143

  19. Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials

    Authors: Paul E. Sax, David A. Wohl, Michael T. Yin, Frank A. Post, Edwin DeJesus, Michael S. Saag, Anton Pozniak, Melanie Thompson, Daniel Podzamczer, Jean‐Michel Molina, Shinichi Oka, Ellen Koenig, Benoît Trottier, Jaime Andrade‐Villanueva, Gordon Crofoot, Joseph M. Custodio, Andrew Plummer, Lijie Zhong, Huyen Cao, Hal Martin, Christian Callebaut, Andrew Cheng, Marshall W. Fordyce, Scott McCallister - The Lancet 2015 cited by 598

  20. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults

    Authors: Michael S. Saag, Constance A. Benson, Rajesh T. Gandhi, Jennifer Hoy, Raphael J. Landovitz, Michael J. Mugavero, Paul E. Sax, Davey M. Smith, Melanie Thompson, Susan Buchbinder, Carlos del Rı́o, Joseph J. Eron, Gerd Fätkenheuer, Huldrych F. Günthard, Jean‐Michel Molina, Donna M. Jacobsen, Paul A. Volberding - JAMA 2018 cited by 559

  21. Lower Pill Burden and Once-Daily Antiretroviral Treatment Regimens for HIV Infection: A Meta-Analysis of Randomized Controlled Trials

    Authors: Jean B. Nachega, Jean-Jacques Parienti, Olalekan A. Uthman, Robert Gross, David W. Dowdy, Paul E. Sax, Joel E. Gallant, Michael J. Mugavero, Edward J. Mills, Thomas P. Giordano - Clinical Infectious Diseases 2014 cited by 352

  22. Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (TDF) Versus Efavirenz/Emtricitabine/TDF in Treatment-naive Adults With Human Immunodeficiency Virus Type 1 Infection: Week 96 Results of the Randomized, Double-blind, Phase 3 DRIVE-AHEAD Noninferiority Trial

    Authors: Chloe Orkin, Kathleen Squires, Jean‐Michel Molina, Paul E. Sax, Otto Sussmann, Gina Lin, Sushma Kumar, George J. Hanna, Carey Hwang, Elizabeth A. Martin, Hedy Teppler - Clinical Infectious Diseases 2020 cited by 79

  23. Characteristics, Comorbidities, and Outcomes in a Multicenter Registry of Patients With Human Immunodeficiency Virus and Coronavirus Disease 2019

    Authors: Dima Dandachi, Grant Geiger, Mary W. Montgomery, Savannah Karmen-Tuohy, Mojgan Golzy, Annukka A.R. Antar, Josep M. Llibre, Maraya Camazine, Alberto Díaz-De Santiago, Philip M. Carlucci, Ioannis M. Zacharioudakis, Joseph Rahimian, Celestine N. Wanjalla, Jihad Slim, Folasade Arinze, Ann Marie Porreca Kratz, Joyce Jones, Shital M. Patel, Ellen Kitchell, Adero Francis, Manoj Ray, David E. Koren, John W. Baddley, B Hill, Paul E. Sax, Jeremy Chow - Clinical Infectious Diseases 2020 cited by 231

  24. Emergent Resistance to Dolutegravir Among INSTI-Naïve Patients on First-line or Second-line Antiretroviral Therapy: A Review of Published Cases

    Authors: Müge Çevik, Chloe Orkin, Paul E. Sax - Open Forum Infectious Diseases 2020 cited by 52